Advertisement

Heart Failure pp 195-218 | Cite as

Acute Decompensated Heart Failure: Treatment Guidelines

Chapter

Abstract

Comprehensive guidelines for the management of ADHF have been published including: the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) Guidelines for the Management of Heart Failure [1], the Heart Failure Society of America (HFSA) Comprehensive Practice Guidelines [2, 3], and the European Society of Cardiology (ESC) Task Force Guidelines [4].

Keywords

Heart Failure Percutaneous Coronary Intervention Right Ventricular Acute Heart Failure Acute Decompensated Heart Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5.CrossRefPubMedGoogle Scholar
  2. 2.
    Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, et al. Heart Failure Society of America, HFSA 2010 Comprehensive Heart Failure Practice Guideline. Section 12: Evaluation and Management of Patients with Acute Decompensated Heart Failure. J Card Fail. 16(6):e131–56. doi: 10.1016/j.cardfail.2010.04.004.
  3. 3.
    Givertz MM, Teerlink JR, Albert NM, Westlake Canary CA, Collins SP, Colvin-Adams M, et al. Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail. 2013;19(6):371–89. doi: 10.1016/j.cardfail.2013.04.002.CrossRefPubMedGoogle Scholar
  4. 4.
    McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, et al; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–69. doi:  10.1093/eurjhf/hfs105. No abstract available. Erratum in: Eur J Heart Fail. 2013;15(3):361.
  5. 5.
    Dickstein K, Cohen-Solal A, Filippatos G, JJ MM, Ponikowski P, PA P-W, et al. ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388–442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17.CrossRefPubMedGoogle Scholar
  6. 6.
    Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al; American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010;122(19):1975–96. doi:  10.1161/CIR.0b013e3181f9a223. Epub 2010 Oct 11.
  7. 7.
    Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725–36. Epub 2006 Sep 25.Google Scholar
  8. 8.
    O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–425. doi:  10.1161/CIR.0b013e3182742cf6. Epub 2012 Dec 17. No abstract available. Erratum in: Circulation. 2013 Dec 24;128(25):e481.
  9. 9.
    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(23):e663–828. doi:  10.1161/CIR.0b013e31828478ac. Epub 2013 Apr 29. No abstract available. Erratum in: Circulation. 2013 Jun 18;127(24):e863–4.
  10. 10.
    Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634–53. Epub 2007 Oct 19.CrossRefPubMedGoogle Scholar
  11. 11.
    Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294(15):1944–56.CrossRefPubMedGoogle Scholar
  12. 12.
    Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR, et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ. 1996;312(7025):222.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, et al. BNP Multinational Study Investigators. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J. 2004;147(6):1078–84.CrossRefPubMedGoogle Scholar
  15. 15.
    Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109(5):594–600.CrossRefPubMedGoogle Scholar
  16. 16.
    Peacock WF, Mueller C, Disomma S, Maisel A. Emergency department perspectives on B-type natriuretic peptide utility. Congest Heart Fail 2008;14(4 Suppl 1):17-20. Review.Google Scholar
  17. 17.
    Maisel A, Mueller C, Adams Jr K, Anker SD, Aspromonte N, Cleland JG, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824–39. doi: 10.1016/j.ejheart.2008.07.014. Epub 2008 Aug 29.CrossRefPubMedGoogle Scholar
  18. 18.
    Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, et al. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med. 2007;167(4):400–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Januzzi Jr JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948–54.CrossRefPubMedGoogle Scholar
  20. 20.
    Januzzi Jr JL, Chen-Tournoux AA, Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol. 2008;101(3A):29–38. doi: 10.1016/j.amjcard.2007.11.017.CrossRefPubMedGoogle Scholar
  21. 21.
    Collins SP, Lindsell CJ, Storrow AB, Abraham WT. ADHERE Scientific Advisory Committee, Investigators and Study Group. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med. 2006;47(1):13–8. Epub 2005 Jun 20.Google Scholar
  22. 22.
    Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27(3):330–7. Epub 2005 Nov 17.CrossRefPubMedGoogle Scholar
  23. 23.
    Collins S, Storrow AB, Albert NM, Butler J, Ezekowitz J, Felker GM, et al. SAEM/HFSA Acute Heart Failure Working Group. Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group. J Card Fail. 2015;21(1):27–43. doi: 10.1016/j.cardfail.2014.07.003. Epub 2014 Jul 18.Google Scholar
  24. 24.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. OPTIMIZE-HF Investigators and Hospitals. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008;168(8):847–54. doi: 10.1001/archinte.168.8.847.CrossRefPubMedGoogle Scholar
  25. 25.
    Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209–16.Google Scholar
  26. 26.
    Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW. ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153(6):1021–8.Google Scholar
  27. 27.
    Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24(5):442–63.Google Scholar
  28. 28.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. OPTIMIZE-HF Investigators and Hospitals. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol. 2009;104(1):107–15. doi: 10.1016/j.amjcard.2009.02.057.CrossRefPubMedGoogle Scholar
  29. 29.
    Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114(11):1202–13.CrossRefPubMedGoogle Scholar
  30. 30.
    Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, et al. Acute Heart Failure Syndromes International Working Group. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009;53(3):254–63. doi: 10.1016/j.jacc.2008.08.072.Google Scholar
  31. 31.
    Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, López-Sendón J, Global Registry of Acute Coronary Events Investigators, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004;109(4):494–9. Epub 2004 Jan 26.CrossRefPubMedGoogle Scholar
  32. 32.
    Wu AH, Parsons L, Every NR, Bates ER. Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 2002;40(8):1389–94.CrossRefPubMedGoogle Scholar
  33. 33.
    Spencer FA, Meyer TE, Gore JM, Goldberg RJ. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002;105(22):2605–10.CrossRefPubMedGoogle Scholar
  34. 34.
    Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287(12):1541–7.Google Scholar
  35. 35.
    McManus DD, Saczynski JS, Lessard D, Kinno M, Pidikiti R, Esa N, et al. Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study). Am J Cardiol. 2013;111(10):1460–5. doi: 10.1016/j.amjcard.2013.01.298.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Rossi JS, Flaherty JD, Fonarow GC, Nunez E, Gattis Stough W, Abraham WT, et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). Eur J Heart Fail. 2008;10(12):1215–23. doi: 10.1016/j.ejheart.2008.09.009. Epub 2008 Nov 8. Now #62.CrossRefPubMedGoogle Scholar
  37. 37.
    Flaherty JD, Rossi JS, Fonarow GC, Nunez E, Stough WG, Abraham WT, et al. Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2009n;157(6):1018–25. doi: 10.1016/j.ahj.2009.03.011. Epub 2009 Apr 23.CrossRefPubMedGoogle Scholar
  38. 38.
    Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, STICH Investigators, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–16. doi: 10.1056/NEJMoa1100356. Epub 2011 Apr 4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, STICH Trial Investigators, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364(17):1617–25. doi: 10.1056/NEJMoa1100358. Epub 2011 Apr 4.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Panza JA, Holly TA, Asch FM, She L, Pellikka PA, Velazquez EJ. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013;61(18):1860–70. doi: 10.1016/j.jacc.2013.02.014. Epub 2013 Mar 7.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344(1):17–22.CrossRefPubMedGoogle Scholar
  42. 42.
    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, OPTIMIZE-HF Investigators and Hospitals. et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50(8):768–777. PubMedGoogle Scholar
  43. 43.
    Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M, Italian survey on Acute Heart Failure Investigators. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27(10):1207–15. Epub 2006 Apr 7. PMID:16603579[PubMed – indexed for MEDLINE 1.CrossRefPubMedGoogle Scholar
  44. 44.
    Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. Circ Heart Fail. 2012;5(2):191–201. doi: 10.1161/CIRCHEARTFAILURE.111.965681. Epub 2012 Feb 23.CrossRefPubMedGoogle Scholar
  45. 45.
    Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–33. doi: 10.1016/j.jacc.2013.11.053. Epub 2014 Feb 5.CrossRefPubMedGoogle Scholar
  46. 46.
    Rosca M Lancellotti P, Popescu BA, LA Piérard. Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart. 2011;97(23):1982–9. doi:  10.1136/heartjnl-2011-300069.
  47. 47.
    Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail. 2015;8(2):295–303. doi: 10.1161/CIRCHEARTFAILURE.114.001667. Epub 2015 Jan 15.CrossRefPubMedGoogle Scholar
  48. 48.
    Eugenio PL. Frequent premature ventricular contractions: an electrical link to cardiomyopathy. Cardiol Rev. 2015;2 Epub ahead of print.Google Scholar
  49. 49.
    El Kadri M, Yokokawa M, Labounty T, Mueller G, Crawford T, Good E, et al. Effect of ablation of frequent premature ventricular complexes on left ventricular function in patients with nonischemic cardiomyopathy. Heart Rhythm. 2015;12(4):706–13. doi: 10.1016/j.hrthm.2014.12.017. Epub 2014 Dec 16.CrossRefPubMedGoogle Scholar
  50. 50.
    Kumar S, Stevenson WG, John RM. Catheter ablation for premature ventricular contractions and ventricular tachycardia in patients with heart failure. Curr Cardiol Rep. 2014;16(9):522. doi: 10.1007/s11886-014-0522-3.CrossRefPubMedGoogle Scholar
  51. 51.
    Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7(7):865–9. doi: 10.1016/j.hrthm.2010.03.036. Epub 2010 Mar 27.CrossRefPubMedGoogle Scholar
  52. 52.
    Michalsen A, König G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80(5):437–41.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Diaz A, Ciocchini C, Esperatti M, Becerra A, Mainardi S, Farah A. Precipitating factors leading to decompensation of chronic heart failure in the elderly patient in South-American community hospital. J Geriatr Cardiol. 2011;8(1):12–4. doi: 10.3724/SP.J.1263.2011.00012.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Wu JR, Moser DK, Chung ML, Lennie TA. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail. 2008;14(7):603–14. doi: 10.1016/j.cardfail.2008.02.011. Epub 2008 May 27.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Mathes T, Jaschinski T, Pieper D. Adherence influencing factors – a systematic review of systematic reviews. Arch Public Health. 2014;72(1):37. doi: 10.1186/2049-3258-72-37. eCollection 2014.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Waldréus N, Hahn RG, Jaarsma T. Thirst in heart failure: a systematic literature review. Eur J Heart Fail. 2013;15(2):141–9. doi: 10.1093/eurjhf/hfs174. Epub 2012 Nov 23.CrossRefPubMedGoogle Scholar
  57. 57.
    Coble JP, Grobe JL, Johnson AK, Sigmund CD. Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ. Am J Phys Regul Integr Comp Phys. 2015;308(4):R238–49. doi: 10.1152/ajpregu.00486.2014. Epub 2014 Dec 17.Google Scholar
  58. 58.
    Menani JV, De Luca Jr LA, Johnson AK. Role of the lateral parabrachial nucleus in the control of sodium appetite. Am J Phys Regul Integr Comp Phys. 2014;306(4):R201–10. doi: 10.1152/ajpregu.00251.2012. Epub 2014 Jan 8.Google Scholar
  59. 59.
    Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci. 2008;9(7):519–31. doi: 10.1038/nrn2400. Epub 2008 May 29.CrossRefPubMedGoogle Scholar
  60. 60.
    Wessler JD, Hummel SL, Maurer MS. Dietary interventions for heart failure in older adults: re-emergence of the hedonic shift. Prog Cardiovasc Dis. 2014;57(2):160–7. doi: 10.1016/j.pcad.2014.03.007. Epub 2014 Mar 12.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Cugno M, Mari D, Meroni PL, Gronda E, Vicari F, Frigerio M, et al. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. Br J Haematol. 2004;126(1):85–92.CrossRefPubMedGoogle Scholar
  62. 62.
    Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol. 1999;33(5):1424–6.CrossRefPubMedGoogle Scholar
  63. 63.
    de Peuter OR, Kok WE, Torp-Pedersen C, Büller HR, Kamphuisen PW. Systolic heart failure: a prothrombotic state. Semin Thromb Hemost. 2009;35(5):497–504. doi: 10.1055/s-0029-1234145. Epub 2009 Sep 8.CrossRefPubMedGoogle Scholar
  64. 64.
    Stein PD, Sostman HD, Hull RD, Goodman LR, Leeper Jr KV, Gottschalk A, et al. Diagnosis of pulmonary embolism in the coronary care unit. Am J Cardiol. 2009;103(6):881–6. doi: 10.1016/j.amjcard.2008.11.040. Epub 2009 Jan 24.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Costanzo MR, Khayat R, Ponikowski P, Augostini R, Stellbrink C, Mianulli M, Abraham WT. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol. 2015;65(1):72–84. doi: 10.1016/j.jacc.2014.10.025.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Valdivia-Arenas MA, Powers M, Khayat RN. Sleep-disordered breathing in patients with decompensated heart failure. Heart Fail Rev. 2009;14(3):183–93. doi: 10.1007/s10741-008-9103-0. Epub 2008 Aug 29.CrossRefPubMedGoogle Scholar
  67. 67.
    Khayat R, Jarjoura D, Porter K, Sow A, Wannemacher J, Dohar R, et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J. 2015; 36:1463–9.Google Scholar
  68. 68.
    Zanotti-Cavazzoni SL, Hollenberg SM. Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care. 2009;15(5):392–7. doi: 10.1097/MCC.0b013e3283307a4e.CrossRefPubMedGoogle Scholar
  69. 69.
    Flynn A, Chokkalingam Mani B, Mather PJ. Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms. Heart Fail Rev. 2010;15(6):605–11. doi: 10.1007/s10741-010-9176-4.CrossRefPubMedGoogle Scholar
  70. 70.
    Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.CrossRefPubMedGoogle Scholar
  71. 71.
    Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142–54. doi: 10.1016/S0140-6736(11)60276-6. Epub 2012 Jan 23.CrossRefPubMedGoogle Scholar
  72. 72.
    Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Investig. 2012;35(3):340–8. doi: 10.3275/8298. Epub 2012 Mar 19.Google Scholar
  73. 73.
    Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894) doi:10.1016/S0140–6736(13)60900–9. Epub 2013 May 30.Google Scholar
  74. 74.
    Gilbert RE, Krum H. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet. 2015;385(9982):2107–17. doi: 10.1016/S0140-6736(14)61402-1.CrossRefPubMedGoogle Scholar
  75. 75.
    Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med. 2005;11(8):861–6. Epub 2005 Jul 10.CrossRefPubMedGoogle Scholar
  76. 76.
    Seki G, Endo Y, Suzuki M, Yamada H, Horita S, Fujita T. Role of renal proximal tubule transport in thiazolidinedione-induced volume expansion. World J Nephrol. 2012;1(5):146–50. doi: 10.5527/wjn.v1.i5.146.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Emoto M, Fukuda N, Nakamori Y, Taguchi A, Okuya S, Oka Y, Tanizawa Y. Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione. Diabetologia. 2006;49(9):2217–8. Epub 2006 Jul 1.CrossRefPubMedGoogle Scholar
  78. 78.
    Murphy N, Mockler M, Ryder M, Ledwidge M, McDonald K. Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain. J Card Fail. 2007;13(3):227–9.CrossRefPubMedGoogle Scholar
  79. 79.
    Curigliano G, Mayer EL, Burstein HJ, Winer EP, Goldhirsch A. Cardiac toxicity from systemic cancer therapy: a comprehensive review. Prog Cardiovasc Dis. 2010;53(2):94–104. doi: 10.1016/j.pcad.2010.05.006.CrossRefPubMedGoogle Scholar
  80. 80.
    Berardi R, Caramanti M, Savini A, Chiorrini S, Pierantoni C, Onofri A, et al. State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review. Crit Rev Oncol Hematol. 2013;88(1):75–86. doi: 10.1016/j.critrevonc.2013.02.007. Epub 2013 Mar 21.CrossRefPubMedGoogle Scholar
  81. 81.
    Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102(1):14–25. doi: 10.1093/jnci/djp440. Epub 2009 Dec 10.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Bhave M, Akhter N, Rosen ST. Cardiovascular toxicity of biologic agents for cancer therapy. Oncology (Williston Park). 2014;28(6):482–90.Google Scholar
  83. 83.
    Accordino MK, Neugut AI, Hershman DL. Cardiac effects of anticancer therapy in the elderly. J Clin Oncol. 2014;32(24):2654–61. doi: 10.1200/JCO.2013.55.0459. Epub 2014 Jul 28.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Iacovoni A, De Maria R, Gavazzi A. Alcoholic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2010;11(12):884–92. doi: 10.2459/JCM.0b013e32833833a3.CrossRefGoogle Scholar
  85. 85.
    Awtry EH, Philippides GJ. Alcoholic and cocaine-associated cardiomyopathies. Prog Cardiovasc Dis. 2010;52(4):289–99. doi: 10.1016/j.pcad.2009.11.004.CrossRefPubMedGoogle Scholar
  86. 86.
    Maraj S, Figueredo VM, Lynn MD. Cocaine and the heart. Clin Cardiol. 2010;33(5):264–9. doi: 10.1002/clc.20746.CrossRefPubMedGoogle Scholar
  87. 87.
    Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9(3):177–96. doi: 10.2165/00129784-200909030-00005.CrossRefPubMedGoogle Scholar
  88. 88.
    Figueredo VM. Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart. Am J Med. 2011;124(6):480–8. doi: 10.1016/j.amjmed.2010.11.031.CrossRefPubMedGoogle Scholar
  89. 89.
    Won S, Hong RA, Shohet RV, Seto TB, Parikh NI. Methamphetamine-associated cardiomyopathy. Clin Cardiol. 2013;36(12):737–42. doi: 10.1002/clc.22195. Epub 2013 Aug 27.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009;54(9):764–76. doi: 10.1016/j.jacc.2009.06.006.CrossRefPubMedGoogle Scholar
  91. 91.
    Akerström F, Pachón M, Puchol A, Jiménez-López J, Segovia D, Rodríguez-Padial L, Arias MA. Chronic right ventricular apical pacing: adverse effects and current therapeutic strategies to minimize them. Int J Cardiol. 2014;173(3):351–60. doi: 10.1016/j.ijcard.2014.03.079. Epub 2014 Mar 20.CrossRefPubMedGoogle Scholar
  92. 92.
    Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, et al. OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217–26.CrossRefPubMedGoogle Scholar
  93. 93.
    Damman K, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL. The cardiorenal syndrome in heart failure. Prog Cardiovasc Dis. 2011;54(2):144–53. doi: 10.1016/j.pcad.2011.01.003.CrossRefPubMedGoogle Scholar
  94. 94.
    Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.PubMedGoogle Scholar
  95. 95.
    Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150(1):85–9.PubMedGoogle Scholar
  96. 96.
    Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J. 2010;31(7):832–41. doi: 10.1093/eurheartj/ehp458. Epub 2009 Nov 11.CrossRefPubMedGoogle Scholar
  97. 97.
    Stevenson LW, Tillisch JH. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation. 1986;74(6):1303–8.CrossRefPubMedGoogle Scholar
  98. 98.
    Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):e391–479. doi:  10.1161/CIRCULATIONAHA.109.192065. Epub 2009 Mar 26.

Copyright information

© Springer-Verlag London 2017

Authors and Affiliations

  1. 1.University of Washington Medical CenterDepartment of Medicine, Division of CardiologySeattleUSA

Personalised recommendations